Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity

Blood

Volumn 90, Issue 6, 1997, Pages 2160-2167

  Szabolcs, Paul ^a   Gallardo, H F ^b   Ciocon, David H ^b   Sadelain, Michel ^b   Young, James W ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD2 ANTIGEN; CD34 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; PROTEIN S 100; VIRUS VECTOR;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DENDRITIC CELL; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOSTIMULATION; IMMUNOTHERAPY; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE ACTIVATION; UMBILICAL CORD BLOOD;

ANTIGEN-PRESENTING CELLS; ANTIGENS, CD2; ANTIGENS, CD34; BONE MARROW CELLS; DENDRITIC CELLS; FETAL BLOOD; FLOW CYTOMETRY; GENETIC ENGINEERING; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY; LEUKEMIA VIRUS, MURINE; LYMPHOCYTE ACTIVATION; SUPERANTIGENS; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

EID: 0030866293     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271, 1991
2. Inaba K, Metlay JP, Crowley MT, Steinman RM: Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med 172:631, 1990
3. Porgador A, Gilboa E: Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 182:255, 1995
4. Paglia P, Chiodoni C, Rodolfo M, Colombo MP: Murine dendritic cells loaded in vitro with soluble protein prime CTL against tumor antigen in vivo. J Exp Med 183:317, 1996
5. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD Jr: Peptide-pulsed dendritic cells induce antigen-specific. CTL-mediated protective tumor immunity. J Exp Med 183:283, 1996
6. Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ: Therapy of murine tumors with tumor peptide pulsed dendritic cells: Dependence on T-cells, B7 costimulation, and Th1-associated cytokines. J Exp Med 183:87, 1996
7. Flamand V, Sornasse T, Thielemans K, Demanet C, Bakkus M, Bazin H, Tielemans F, Leo O, Urbain J, Moser M: Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol 24:605, 1994
8. Steinman RM, Lustig DS, Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. III. Functional properties in vivo. J Exp Med 139:1431, 1974
9. Katz SI, Tamaki K, Sachs DH: Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 282:324, 1979
10. Volc-Platzer B, Stingl G, Wolff K, Hinterberg W, Schnedl W: Cytogenetic identification of allogeneic epidermal Langerhans cells in a bone marrow graft recipient. N Engl J Med 310:1123, 1984
11. Young JW, Koulova L, Soergel SA, Clark EA, Steinman RM, Dupont B: The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. J Clin Invest 90:229, 1992
12. Freudenthal PS, Steinman RM: The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci USA 87:7698, 1990
13. O'Doherty U, Steinman RM, Peng M, Cameron PU, Gezelter S, Kopeloff I, Swiggard WJ, Pope M, Bhardwaj N: Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J Exp Med 178:1067, 1993
14. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J: GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360:258, 1992
15. Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE: TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol 52:274, 1992
16. + progenitors in human bone marrow. J Immunol 149:2681, 1992
17. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-α. J Immunol 154:5851, 1995
18. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α. J Exp Med 182:1111, 1995 [correction 183:1283, 1996]
19. + hematopoietic progenitor cells. Blood 87:1292, 1996
20. Szabolcs P, Avigan D, Gezelter S, Ciocon DH, Moore MAS, Steinman RM, Young JW: Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-CFU intermediate. Blood 87:4520, 1996
21. Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant C, de Saint-Vis B, Jacquet C, Yoneda K, Imamura S, Schmitt D, Banchereau J: CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+ TNF α. J Exp Med 184:695, 1996
22. Takahashi H, Nakagawa Y, Yokomuro K, Berzofsky JA: Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int Immunol 5:849, 1993
23. Boczkowski D, Nair SK, Snyder D, Gilboa E: Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 184:465, 1996
24. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ilstad ST, Kast WM, DeLeo AB, Lotze MT: Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med 1:1297, 1995
25. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R: Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 2:52, 1996
26. + cord blood cells is expressed by their T-cell progeny in the SCID-hu thymus. Blood 88:107, 1996
27. Danos O, Mulligan R: Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 85:6460, 1988
28. Riviere I, Brose K, Mulligan RC: Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA 92:6733, 1995
29. Riviere I, Sadelain M: Methods for the construction of retroviral vectors and the generation of high titer producers, in Robbins P (ed): Gene Therapy Protocols: Methods in Molecular Biology. Totowa, NJ, Humana, 1996, p 59
30. Gallardo HF, Tan C, Ory D, Sadelain M: Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood 90:952, 1997
31. Mosialos G, Birkenbach M, Ayehunie S, Matsumura F, Pinkus GS, Kieff E, Langhoff E: Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein. Am J Pathol 148:593, 1996
32. Young JW, Steinman RM: Accessory cell requirements for the mixed leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells. Cell Immunol 111:167, 1988
33. Knight SC, Farrant J, Bryant A, Edwards AJ, Burman S, Lever A, Clarke J, Webster ADB: Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. Immunology 57:595, 1986
34. Young JW, Baggers J, Soergel SA: High dose UV-B radiation alters dendritic cell costimulatory activity but does not tolerize T lymphocytes to alloantigen in vitro. Blood 81:2987, 1993
35. Kasinrerk W, Baumruker T, Majdic O, Knapp W, Stockinger H: CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor. J Immunol 150:579, 1993
36. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239, 1990
37. Roe TY, Reynolds TC, Yu G, Brown PO: Integration of murine leukemia virus DNA depends on mitosis. EMBO J 12:2099, 1993
38. Hajihosseini M, Lavechev L, Price J: Evidence that retroviruses integrate into post-replication host DNA. EMBO J 12:4969, 1993
39. Alijagic S, Moller P, Artuc M, Jurgovsky K, Czarnetzki BM, Schadendorf D: Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur J Immunol 25:3100, 1995
40. Arthur JF, Butterfield LH, Roth MD, Bui LA, Kiertscher SM, Lau R, Dubinett S, Glaspy J, McBride WH, Economou JS: A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther 4:17, 1997
41. Moritz T, Keller DC, Williams DA: Human cord blood cells as targets for gene transfer: Potential use in genetic therapies of severe combined immunodeficiency disease. J Exp Med 178:529, 1993
42. Henderson RA, Nimgaonkar MT, Watkins SC, Robbins PD, Ball ED, Finn OJ: Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin [MUC-1]. Cancer Res 56:3763, 1996
43. Reeves ME, Royal RE, Lam JS, Rosenberg SA, Hwu P: Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res 56:5672, 1996
44. Aicher A, Westermann J, Cayeux S, Willimsky G, Daemen K, Blankenstein T, Uckert W, Dorken B, Pezzutto A: Successful retroviral mediated transduction of a reporter gene in human dendritic cells: Feasibility of therapy with gene-modified antigen presenting cells. Exp Hematol 25:39, 1997
45. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N: Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196:121, 1996
46. Romani N, Reider D, Heuer M, Ebner S, Eibl B, Niederwieser D, Schuler G: Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability. J Immunol Methods 196:137, 1996